Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics.
Deep Intelligent Pharma is a Singapore based AI Clinical Trial Company
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
TianTi Biotherapeutics is a biotechnology company that provides research and development of antibody drugs.
Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
PaXini Tech is a research and development company for tactile technology and adaptive robots.
West Lake Xinchen is a technology company which develops psychological counseling robots to provide mental health services.
Xihu Xinchen is a technology company focusing on the research and development of artificial intelligence services.
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.
Levinthal provides protein design and co-evolution using artificial intelligence for food safety and medical care.
Junsai Shengwu is a biotechnology company that develops novel therapeutic approaches for new solid tumor cell .
Youxin Cloud is a PaaS cloud service company that offers digital transformation, cloud computing, and big data solutions for enterprises.
Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains.
Huaboron Neutron develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers.
Pleryon Therapeutics is a drug delivery platform company.
Xinbele Bio is a biotechnology company that specializes in synthetic biology research, development and transformation of enzymes.
Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering.
Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).
Ruixun Biotech is a healthcare company that provides biotechnology.
Xinyue is a audio and video asset management and collaborative delivery brand to help users with intelligent audio-video workflow.
TechnoDerma Medicines is engaged in the research and development of skin drugs for external use.
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases
Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.
Kaitai Capital has invested in 80 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Kaitai Capital's top investment sectors include Biotechnology, Pharmaceutical, Biopharma, Health Care, Artificial Intelligence (AI). The firm invests across 23 different industry categories.
Among tracked funding rounds, PaXini Tech received $145.1M in a Series B round. Kaitai Capital's total known invested capital is $874.5M.
Kaitai Capital's average investment size is $16.5M across its portfolio of 80 companies.
Recent Kaitai Capital portfolio additions include Anji Pharmaceuticals, Deep Intelligent Pharma, BridGene Biosciences, TianTi Biotherapeutics, Mingsight Pharmaceuticals. These companies were founded in 2020 or later.